Whitehawk Therapeutics, Inc. SEC filings WHWK

Whitehawk Therapeutics, Inc. has 671 filings in SEC EDGAR's recent list, going back to Feb 1, 2008. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 10, 2026 (officer or director change). The company's fiscal year ends on December 31.

Whitehawk Therapeutics, Inc. SEC filings
Form Description Filed Period
8-K Current report
Officer or director change
Sep 10, 2026 Sep 9, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
8-K Current report
Shareholder vote results
Jun 12, 2026 Jun 11, 2026
EFFECT Filing Jun 9, 2026 —
CORRESP Letter to the SEC Jun 5, 2026 —
UPLOAD Letter from the SEC Jun 5, 2026 —
S-3 Shelf registration May 29, 2026 —
8-K Current report
Other events
May 21, 2026 May 21, 2026
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
May 13, 2026 May 12, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
DEFA14A Additional proxy material Apr 28, 2026 —
ARS Annual report to shareholders Apr 28, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 28, 2026 Apr 28, 2026
S-8 Employee stock plan registration Mar 12, 2026 —
10-K Annual report Mar 12, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 12, 2026 Mar 12, 2026
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
8-K Current report
Shareholder vote results
Jun 13, 2025 Jun 11, 2025
UPLOAD Letter from the SEC May 22, 2025 —
CORRESP Letter to the SEC May 13, 2025 —
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
UPLOAD Letter from the SEC May 7, 2025 —
ARS Annual report to shareholders Apr 28, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 28, 2025 —
DEF 14A Proxy statement Apr 28, 2025 Jun 11, 2025
424B5 Prospectus supplement Apr 25, 2025 —
EFFECT Filing Apr 8, 2025 —
CORRESP Letter to the SEC Apr 4, 2025 —
UPLOAD Letter from the SEC Apr 4, 2025 —
S-3 Shelf registration Mar 31, 2025 —
8-K/A Amended current report Mar 31, 2025 Mar 25, 2025
S-8 Employee stock plan registration Mar 28, 2025 —
10-K Annual report Mar 28, 2025 Dec 31, 2024
8-K Current report
Acquisition or sale of assets
Mar 26, 2025 Mar 25, 2025
8-K Current report
Results of operations, Bylaw or fiscal year change
Mar 18, 2025 Mar 18, 2025
D Filing Mar 18, 2025 —
8-K Current report
Material agreement, Shareholder vote results, Regulation FD disclosure
Mar 4, 2025 Feb 28, 2025
DEFA14A Additional proxy material Feb 19, 2025 —
DEFA14A Additional proxy material Feb 18, 2025 —
DEFA14A Additional proxy material Feb 5, 2025 —
DEFM14A Filing Jan 31, 2025 —
PREM14A Filing Jan 21, 2025 Jan 21, 2025
DEFA14A Additional proxy material Dec 30, 2024 —
DEFA14A Additional proxy material Dec 20, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Regulation FD disclosure
Dec 20, 2024 Dec 19, 2024
10-Q Quarterly report Nov 6, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 6, 2024 Nov 6, 2024
8-K Current report
Other events
Sep 30, 2024 Sep 26, 2024
8-K Current report
Officer or director change
Sep 19, 2024 Sep 15, 2024
8-K Current report
Officer or director change
Aug 22, 2024 Aug 16, 2024
8-K Current report
Exit or restructuring costs, Other events
Aug 21, 2024 Aug 16, 2024
10-Q Quarterly report Aug 7, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 7, 2024 Aug 7, 2024
8-K Current report
Shareholder vote results
Jun 12, 2024 Jun 11, 2024
10-Q Quarterly report May 8, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 8, 2024 May 8, 2024
424B5 Prospectus supplement May 3, 2024 —
EFFECT Filing Apr 30, 2024 —
CORRESP Letter to the SEC Apr 26, 2024 —
ARS Annual report to shareholders Apr 26, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Jun 11, 2024
8-K Current report
Material agreement
Apr 4, 2024 Apr 1, 2024
10-K Annual report Mar 13, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 13, 2024 Mar 13, 2024
UPLOAD Letter from the SEC Feb 20, 2024 —
S-8 Employee stock plan registration Feb 12, 2024 —
S-3 Shelf registration Feb 12, 2024 —
8-K Current report
Other events
Dec 14, 2023 Dec 14, 2023
10-Q Quarterly report Nov 8, 2023 Sep 30, 2023
8-K/A Amended current report
Results of operations
Nov 8, 2023 Nov 8, 2023
8-K Current report
Results of operations
Nov 8, 2023 Nov 8, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 2, 2023 Sep 27, 2023
10-Q Quarterly report Aug 9, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 9, 2023 Aug 9, 2023
8-K Current report
Shareholder vote results
Jun 16, 2023 Jun 14, 2023
10-Q Quarterly report May 10, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 10, 2023 May 10, 2023
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 28, 2023 —
DEF 14A Proxy statement Apr 28, 2023 —
S-8 Employee stock plan registration Mar 29, 2023 —
10-K Annual report Mar 29, 2023 Dec 31, 2022
8-K/A Amended current report
Officer or director change
Mar 28, 2023 Mar 2, 2023
8-K Current report
Results of operations, Officer or director change
Mar 28, 2023 Mar 24, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 3, 2023 Mar 2, 2023
8-K Current report
Material agreement
Jan 23, 2023 Jan 17, 2023
8-K Current report
Bylaw or fiscal year change
Dec 7, 2022 Dec 6, 2022
8-K Current report
Listing notice
Nov 28, 2022 Nov 23, 2022
10-Q Quarterly report Nov 9, 2022 Sep 30, 2022
8-K Current report
Results of operations, Officer or director change
Nov 9, 2022 Nov 8, 2022
EFFECT Filing Nov 4, 2022 —
424B3 Prospectus Nov 4, 2022 —
CORRESP Letter to the SEC Nov 2, 2022 —
UPLOAD Letter from the SEC Nov 1, 2022 —
S-3 Shelf registration Oct 26, 2022 —
D Filing Oct 11, 2022 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Sep 22, 2022 Sep 22, 2022
10-Q Quarterly report Aug 10, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 10, 2022 Aug 10, 2022
8-K Current report
Agreement ended
Jun 30, 2022 Jun 27, 2022
8-K Current report
Shareholder vote results
Jun 17, 2022 Jun 14, 2022
10-Q Quarterly report May 12, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 12, 2022 May 12, 2022
DEFA14A Additional proxy material Apr 26, 2022 —
DEF 14A Proxy statement Apr 26, 2022 Jun 14, 2022
424B5 Prospectus supplement Mar 21, 2022 —
424B5 Prospectus supplement Mar 17, 2022 —
8-K Current report
Material agreement
Mar 17, 2022 Mar 17, 2022
S-8 Employee stock plan registration Mar 17, 2022 —
10-K Annual report Mar 17, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 17, 2022 Mar 17, 2022
8-K Current report
Material agreement
Jan 20, 2022 Jan 13, 2022
8-K Current report
Other events
Nov 23, 2021 Nov 23, 2021
10-Q Quarterly report Nov 10, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 10, 2021 Nov 10, 2021
8-K Current report
Officer or director change, Regulation FD disclosure
Nov 1, 2021 Oct 28, 2021
424B3 Prospectus Oct 4, 2021 —
EFFECT Filing Oct 1, 2021 —
CORRESP Letter to the SEC Sep 30, 2021 —
UPLOAD Letter from the SEC Sep 29, 2021 —
S-8 Employee stock plan registration Sep 24, 2021 —
S-3 Shelf registration Sep 24, 2021 —
8-K/A Amended current report Sep 24, 2021 Aug 26, 2021
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 20, 2021 Sep 14, 2021
8-K Current report
Auditor change, Officer or director change
Sep 13, 2021 Sep 8, 2021
D Filing Sep 10, 2021 —
D Filing Sep 10, 2021 —
8-K Current report
Material agreement
Sep 3, 2021 Aug 30, 2021
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change
Aug 27, 2021 Aug 26, 2021
8-K Current report
Material agreement
Aug 23, 2021 Aug 17, 2021
8-K Current report
Shareholder vote results
Aug 18, 2021 Aug 17, 2021
10-Q Quarterly report Aug 11, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 11, 2021 Aug 11, 2021
8-K Current report
Shareholder vote results, Regulation FD disclosure
Jul 26, 2021 Jul 22, 2021
DEFM14A Filing Jul 8, 2021 —
PREM14A Filing Jun 21, 2021 Jun 21, 2021
DEFA14A Additional proxy material Jun 9, 2021 —
DEF 14A Proxy statement Jun 9, 2021 Jul 22, 2021
DEFA14A Additional proxy material Jun 4, 2021 —
8-K Current report
Regulation FD disclosure
Jun 4, 2021 Jun 4, 2021
DEFA14A Additional proxy material May 20, 2021 —
8-K Current report
Regulation FD disclosure
May 20, 2021 May 19, 2021
10-Q Quarterly report May 17, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 17, 2021 May 17, 2021
8-K Current report
Material agreement, Unregistered share sale, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
May 17, 2021 May 16, 2021
DEFA14A Additional proxy material May 17, 2021 —
EFFECT Filing Apr 15, 2021 —
CORRESP Letter to the SEC Apr 13, 2021 —
UPLOAD Letter from the SEC Apr 12, 2021 —
S-3 Shelf registration Apr 8, 2021 —
8-K Current report
Officer or director change
Apr 1, 2021 Mar 29, 2021
10-K Annual report Mar 11, 2021 Dec 31, 2020
8-K Current report
Results of operations
Mar 11, 2021 Mar 11, 2021
8-K Current report
Other events
Mar 5, 2021 Mar 5, 2021
8-K Current report
Officer or director change
Feb 16, 2021 Feb 9, 2021
8-K Current report
Exit or restructuring costs, Officer or director change
Feb 1, 2021 Jan 26, 2021
8-K Current report
Other events
Jan 5, 2021 Jan 5, 2021
8-K Current report
Other events
Dec 11, 2020 Dec 11, 2020
10-Q Quarterly report Nov 10, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 10, 2020 Nov 10, 2020
424B5 Prospectus supplement Sep 25, 2020 —
10-Q Quarterly report Aug 12, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 12, 2020 Aug 12, 2020
424B5 Prospectus supplement Aug 5, 2020 —
8-K Current report
Regulation FD disclosure, Other events
Aug 4, 2020 Aug 4, 2020
8-K Current report
Shareholder vote results, Other events
Jun 25, 2020 Jun 24, 2020
DEFA14A Additional proxy material Jun 8, 2020 —
8-K Current report
Regulation FD disclosure, Other events
May 28, 2020 May 27, 2020
8-K Current report
Material agreement, Other events
May 12, 2020 May 11, 2020
DEFA14A Additional proxy material May 8, 2020 —
10-Q Quarterly report May 7, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 7, 2020 May 7, 2020
DEFA14A Additional proxy material Apr 27, 2020 —
DEF 14A Proxy statement Apr 27, 2020 Jun 24, 2020
PRE 14A Preliminary proxy statement Apr 17, 2020 Jun 24, 2020
S-8 Employee stock plan registration Mar 16, 2020 —
10-K Annual report Mar 16, 2020 Dec 31, 2019
8-K Current report
Results of operations
Mar 16, 2020 Mar 16, 2020
8-K Current report
Listing notice
Jan 27, 2020 Jan 21, 2020
8-K Current report
Other events
Jan 8, 2020 Jan 8, 2020
10-Q Quarterly report Nov 7, 2019 Sep 30, 2019
8-K Current report
Results of operations, Officer or director change
Nov 7, 2019 Nov 4, 2019
8-K Current report
Officer or director change
Oct 18, 2019 Oct 15, 2019
8-K Current report
Other events
Oct 10, 2019 Oct 10, 2019
10-Q Quarterly report Aug 8, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 8, 2019 Aug 8, 2019
8-K Current report
Listing notice
Jul 26, 2019 Jul 24, 2019
8-K Current report
Shareholder vote results
Jun 19, 2019 Jun 18, 2019
8-K Current report
Officer or director change, Other events
May 16, 2019 May 14, 2019
10-Q Quarterly report May 9, 2019 Mar 31, 2019
8-K Current report
Results of operations
May 9, 2019 May 9, 2019
DEFA14A Additional proxy material Apr 30, 2019 —
DEF 14A Proxy statement Apr 30, 2019 Jun 18, 2019

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
WHWK (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Morristown, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1422142
Former names
Aadi Bioscience, Inc. (until Mar 18, 2025); Aerpio Pharmaceuticals, Inc. (until Aug 23, 2021); ZETA ACQUISITION CORP II (until Mar 13, 2017)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.